|
Florida Veterinary Specialists Cancer Treatment Center has teamed with a local oncologic research center to test a novel lymphosarcoma vaccine for treatment of canine lymphosarcoma. The vaccine is generated through in-vitro culture and sterilization of the patients own malignant cells. This is a fascinating new area of research for lymphosarcoma in people that will be applied to veterinary patients.
Eligibility:
· Dogs recently diagnosed with lymphosarcoma.
· Otherwise appear healthy.
· Owners decline conventional therapy (chemotherapy, prednisone)
· No recent history of prednisone.
What’s Covered:
· Initial staging of the disease (CBC, Chemistry Panel, U/A, Abdominal Ultrasound).
· Cytology/histopathology, as needed.
· Custom vaccine manufactured from the patient’s own neoplastic cells.
· Vaccine administration, rechecks and follow up.
Who to Contact:
· Dr. Curtis Kane, FVS Oncology Service (813-933-8944).
Please call Dr. Kane directly to discuss potential candidates. This is a fantastic option for clients who are either unable or unwilling to elect conventional therapy.
Back
|
